Nathaniel Wang, Replicate Bioscience CEO
Replicate Bioscience takes aim at mono-causing virus after promising results with mRNA rabies shot
Replicate Bioscience, a San Diego startup developing a second-generation mRNA vaccine technology that could spur stronger immunity with smaller doses, said its experimental rabies shots …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.